No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia

Journal of Clinical Oncology

Volumn 28, Issue 28, 2010, Pages

  Hollink, Iris H I M ^a   Van Den Heuvel Eibrink, Marry M ^a   Zimmermann, Martin ^b   Balgobind, Brian V ^a   Arentsen Peters, Susan T C J M ^a   Alders, Marielle ^c   Willasch, Andre ^d   Kaspers, Gert Jan J L ^e   Trka, Jan ^f   Baruchel, Andre ^g   Creutzig, Ursula ^b   Pieters, Rob ^a   Reinhardt, Dirk ^b   Zwaan, C Michel ^a,h  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^f CHARLES UNIVERSITY   (Czech Republic)

^g SAINT LOUIS HOSPITAL   (France)

^h DUTCH CHILDHOOD ONCOLOGY GROUP   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; WT1 PROTEIN; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; CHILD; CONTROLLED STUDY; CYTOGENETICS; EVENT FREE SURVIVAL; FEMALE; GENE DUPLICATION; GENE EXPRESSION; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; HIGH RISK PATIENT; HUMAN; INTERNAL TANDEM DUPLICATION; KARYOTYPE; LETTER; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT; ALLELE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; GERMANY; MUTATION; NETHERLANDS; NOTE; SURVIVAL RATE;

ALLELES; CHILD; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GERMANY; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MUTATION; NETHERLANDS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 78049436798     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.3860     Document Type: Letter

References (12)

1. Damm F, Heuser M, Morgan M, et al: Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia. J Clin Oncol 28:578-585, 2010
2. Virappane P, Gale R, Hills R, et al: Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 26:5429-5435, 2008
3. Paschka P, Marcucci G, Ruppert AS, et al: Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: A cancer and leukemia group B study. J Clin Oncol 26:4595-4602, 2008
4. Renneville A, Boissel N, Zurawski V, et al: Wilms tumor 1 gene mutations are associated with a higher risk of recurrence in young adults with acute myeloid leukemia: A study from the Acute Leukemia French Association. Cancer 115:3719-3727, 2009
5. Gaidzik VI, Schlenk RF, Moschny S, et al: Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: A study of the German-Austrian AML Study Group. Blood 113:4505-4511, 2009
6. Noronha SA, Farrar JE, Alonzo TA, et al: WT1 expression at diagnosis does not predict survival in pediatric AML: A report from the Children's Oncology Group. Pediatr Blood Cancer 53:1136-1139, 2009
7. Rodrigues PC, Oliveira SN, Viana MB, et al: Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia. Pediatr Blood Cancer 49:133-138, 2007 (Pubitemid 47041101)
8. Schmid D, Heinze G, Linnerth B, et al: Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia 11:639-643, 1997 (Pubitemid 27241240)
9. Bergmann L, Miething C, Maurer U, et al: High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 90:1217-1225, 1997 (Pubitemid 27314159)
10. Hollink IH, van den Heuvel-Eibrink MM, Zimmermann M, et al: Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia. Blood 113:5951-5960, 2009
11. Willasch AM, Gruhn B, Coliva T, et al: Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: A European multicenter study. Leukemia 23:1472-1479, 2009
12. Hollink IH, Zwaan CM, Zimmermann M, et al: Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia 23:262-270, 2009